Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Multiple Dose Japanese Bridging Study [Phase 1]
A Phase 1 multiple-dose Japanese bridging study for an Alzheimer's disease candidate has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: A Study of the Safety and Effectiveness of Galantamine in Patients With Alzheimer's Disease [Phase 3]
Phase 3 trial update on the safety and effectiveness of galantamine in patients with Alzheimer disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-24Clinical Trial Update: The Efficacy of Galantamine on the Attention and the Frontal Function of the Patients With Dementia of Alzheimer Type [Phase 4]
Phase 4 trial update evaluating galantamine's effect on attention and frontal function in Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2011-01-14Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
A Phase 3 trial evaluated the effectiveness and safety of risperidone for behavioral disturbances in dementia patients and has completed.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Effect on the Electrocardiographic QT Interval Corrected for Heart Rate (QTc) in Healthy Subjects [Phase 1]
A Phase 1 QTc study by Bristol-Myers Squibb in healthy subjects has been completed, with Alzheimer’s disease listed as the associated condit…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease [Phase 1]
This clinical trial update notes the completion of a Phase 1 relative bioavailability study evaluating four experimental formulations for Al…
-
CLINICAL_TRIALS trial_result · 2010-12-24Clinical Trial Update: Evaluation of the COGNISION(TM) System as an Event-related Potential (ERP) Collection System.
A completed clinical trial evaluating the COGNISION ERP collection system for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2010-12-17Clinical Trial Update: Multiple Dose Study of TRx0037 [Phase 1]
Phase 1 multiple-dose trial of TRx0037 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-10Clinical Trial Update: Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD0328 in Elderly Healthy Subjects [Phase 1]
Phase 1 trial update assessing safety, tolerability, pharmacokinetics and pharmacodynamics of AZD0328 in elderly healthy subjects; the study…
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
Phase 3 randomized trial comparing risperidone to placebo for behavioral disturbances in dementia patients has completed.
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Comparative Bioavailability in Healthy Elderly Volunteers [Phase 1]
Phase 1 trial update reporting the comparative bioavailability of TauRx's Alzheimer’s disease drug in healthy elderly volunteers. The study …
-
CLINICAL_TRIALS trial_result · 2010-12-03Clinical Trial Update: Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease [Phase 4]
A Phase 4 trial assessing memantine's effects on biological markers and brain PET imaging in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-19Clinical Trial Update: A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With Dementia [Phase 3]
This document reports results from a Phase 3 trial evaluating the effectiveness and safety of risperidone for behavioral disturbances in pat…
-
CLINICAL_TRIALS trial_result · 2010-11-18Clinical Trial Update: MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) [Phase 2]
A Phase 2 trial evaluating MK0249 for symptomatic treatment of Alzheimer's disease has completed. The results were posted in November 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-05Clinical Trial Update: Alzheimer's Disease Prevention Trial [Phase 3]
A Phase 3 Alzheimer's disease prevention trial conducted by the National Institute on Aging has completed.
-
CLINICAL_TRIALS trial_result · 2010-11-02Clinical Trial Update: A Safety and Tolerability Study of ABT-126 in Elderly [Phase 1]
A Phase 1 safety and tolerability trial of ABT-126 in elderly individuals with Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2010-10-27Clinical Trial Update: A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease [Phase 1]
This phase 1 trial update evaluates safety, pharmacokinetics, pharmacodynamics, and immunogenicity of the anti-amyloid beta antibody MABT510…
-
CLINICAL_TRIALS trial_result · 2010-10-20Clinical Trial Update: Valproate in Dementia (VALID) [Phase 3]
A Phase 3 trial (VALID) evaluated valproate in dementia (Alzheimer's disease); the study has completed and results were posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of Affitope AD01 in Mild to Moderate Alzheimer's Disease [Phase 1]
This Phase 1 study evaluates the tolerability and safety of subcutaneous Affitope AD01 in patients with mild to moderate Alzheimer's disease…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Safety/Tolerability, Immunological and Clinical Activity of a Boost Immunization With AFFITOPE AD02 [Phase 1]
A Phase 1 trial evaluating the safety, tolerability, immune response, and clinical activity of a booster immunization with AFFITOPE AD02 in …
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Tolerability and Safety of Subcutaneous Administration of AFFITOPE AD02 in Mild to Moderate Alzheimer's Disease [Phase 1]
Phase 1 study evaluating tolerability and safety of subcutaneous AFFITOPE AD02 in individuals with mild to moderate Alzheimer's disease; the…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Evaluation of [123I] AV151 and SPECT in Subjects w/ AD in Comparison to Healthy Subjects [Phase 1]
Phase 1 evaluation of the radiotracer [123I] AV151 for SPECT imaging in Alzheimer's disease subjects compared to healthy controls; the trial…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Safety and Efficacy of Positron Emission Tomography Imaging With MNI-513 [EARLY_Phase 1]
An EARLY_PHASE1 clinical trial evaluating the safety and efficacy of the PET imaging agent MNI-513 for Alzheimer's disease has been terminat…
-
CLINICAL_TRIALS trial_result · 2010-10-06Clinical Trial Update: Evaluation of [123I] AV94 and SPECT in Subjects With Alzheimer Disease in Comparison to Healthy Subjects [Phase 1]
Phase 1 study evaluating the radiolabeled imaging agent AV94 with SPECT in individuals with Alzheimer disease compared to healthy controls; …
-
CLINICAL_TRIALS trial_result · 2010-09-16Clinical Trial Update: A Study of the Safety and Efficacy of Memantine in Moderate to Severe Alzheimer's Disease [Phase 3]
A Phase 3 study evaluating memantine for moderate to severe Alzheimer's disease has completed, with results posted in 2010.